Skip to main content
SpringerLink
Log in

Hybrid MR-PET in Neuroimaging

  • Original Article
  • Published:
Clinical Neuroradiology Aims and scope Submit manuscript

Abstract

Hybrid magnetic resonance (MR)-positron emission tomography (MR-PET) is a novel technology with advantages over sequential MR and PET imaging, allowing maintain full individual diagnostic performance with negligible mutual interference between the two hardware settings. Obvious synergies between MR and PET in acquisition of anatomical, functional, and molecular information for neurological diseases into one single image pave the way for establishing clear clinical indications for hybrid MR-PET as well as addressing unmet neuroimaging needs in future clinics and research. Further developments in attenuation correction, quantification, workflow, and effective MR-PET data management might unfold the full potential of integrated multimodality imaging.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Judenhofer MS, Wehrl HF, Newport DF, Catana C, Siegel SB, Becker M, Thielscher A, Kneilling M, Lichy MP, Eichner M, Klingel K, Reischl G, Widmaier S, Röcken M, Nutt RE, Machulla HJ, Uludag K, Cherry SR, Claussen CD, Pichler BJ. Simultaneous PET-MRI: a new approach for functional and morphological imaging. Nat Med. 2008;14(4):459–65.

    Article  CAS  PubMed  Google Scholar 

  2. Zaidi H, Del Guerra A. An outlook on future design of hybrid PET/MRI systems. Med Phys. 2011;38(10):5667-89.

    Article  PubMed  Google Scholar 

  3. Keereman V, Mollet P, Berker Y, Schulz V, Vandenberghe S. Challenges and current methods for attenuation correction in PET/MR. Magma. 2013;26(1):81–98.

    Article  PubMed  Google Scholar 

  4. Hofmann M, Bezrukov I, Mantlik F, Aschoff P, Steinke F, Beyer T, Pichler BJ, Schölkopf B.MRI-based attenuation correction for whole-body PET/MRI: quantitative evaluation of segmentation- and atlas-based methods. J Nucl Med. 2011;52(9):1392-9.

    Article  Google Scholar 

  5. Vargas MI, Becker M, Garibotto V, Heinzer S, Loubeyre P, Gariani J, Lovblad K, Vallée JP, Ratib O. Approaches for the optimization of MR protocols in clinical hybrid PET/MRI studies. Magma. 2013;26(1):57–69.

    Article  PubMed  Google Scholar 

  6. Yankeelov TE, Peterson TE, Abramson RG, Izquierdo-Garcia D, Arlinghaus LR, Li X, Atuegwu NC, Catana C, Manning HC, Fayad ZA, Gore JC. Simultaneous PET-MRI in oncology: a solution looking for a problem? Magn Reson Imaging. 2012;30(9):1342–56.

    Article  PubMed Central  PubMed  Google Scholar 

  7. Shidahara M, Tsoumpas C, Hammers A, Boussion N, Visvikis D, Suhara T, Kanno I, Turkheimer FE. Functional and structural synergy for resolution recovery and partial volume correction in brain PET. NeuroImage. 2009;44(2):340–8.

    Article  PubMed  Google Scholar 

  8. Tsoumpas C, Mackewn JE, Halsted P, King AP, Buerger C, Totman JJ, Schaeffter T, Marsden PK. Simultaneous PET-MR acquisition and MR-derived motion fields for correction of non-rigid motion in PET. Ann Nucl Med. 2010;24(10):745–50.

    Article  PubMed  Google Scholar 

  9. Hoehn M, Himmelreich U, Kruttwig K, Wiedermann D. Molecular and cellular MR imaging: potentials and challenges for neurological applications. J Magn Reson Imaging. 2008;27(5):941–54.

    Article  PubMed  Google Scholar 

  10. Lee HY, Li Z, Chen K, Hsu AR, Xu C, Xie J, Sun S, Chen X. PET/MRI dual-modality tumor imaging using arginine-glycine-aspartic (RGD)-conjugated radiolabeled iron oxide nanoparticles. J Nucl Med. 2008;49(8):1371–9.

    Article  CAS  PubMed  Google Scholar 

  11. Schäfer JF, Gatidis S, Schmidt H, Gückel B, Bezrukov I, Pfannenberg CA, Reimold M, Ebinger M, Fuchs J, Claussen CD, Schwenzer NF. Simultaneous whole-body PET/MR imaging in comparison to PET/CT in pediatric oncology: initial results. Radiology. 2014;273(1):220–31.

    Article  PubMed  Google Scholar 

  12. Bisdas S, Ritz R, Bender B, Braun C, Pfannenberg C, Reimold M, Naegele T, Ernemann U. Metabolic mapping of gliomas using hybrid MR-PET imaging: feasibility of the method and spatial distribution of metabolic changes. Invest Radiol. 2013;48(5):295–301.

    Article  CAS  PubMed  Google Scholar 

  13. Gempt J, Soehngen E, Förster S, Ryang YM, Schlegel J, Zimmer C, Meyer B, Ringel F, Grams AE, Förschler A. Multimodal imaging in cerebral gliomas and its neuropathological correlation. Eur J Radiol. 2014;83(5):829–34.

    Article  PubMed  Google Scholar 

  14. Weller M, Pfister SM, Wick W, Hegi ME, Reifenberger G, Stupp R. Molecular neuro-oncology in clinical practice: a new horizon. Lancet Oncol. 2013;14(9):e370–9.

    Article  CAS  PubMed  Google Scholar 

  15. Seeger A, Braun C, Skardelly M, Paulsen F, Schittenhelm J, Ernemann U, Bisdas S. Comparison of three different MR perfusion techniques and MR spectroscopy for multiparametric assessment in distinguishing recurrent high-grade gliomas from stable disease. Acad Radiol. 2013;20(12):1557–65.

    Article  PubMed  Google Scholar 

  16. la Fougere C, Suchorska B, Bartenstein P, Kreth FW, Tonn JC. Molecular imaging of gliomas with PET: opportunities and limitations. Neuro-oncology. 2011;13(8):806–19.

    Article  PubMed Central  PubMed  Google Scholar 

  17. Thorwarth D, Henke G, Müller AC, Reimold M, Beyer T, Boss A, Kolb A, Pichler B, Pfannenberg C. Simultaneous 68Ga-DOTATOC-PET/MRI for IMRT treatment planning for meningioma: first experience. Int J Radiat Oncol Biol Phys. 2011;81(1):277–83.

    Article  PubMed  Google Scholar 

  18. Furtner J, Bender B, Braun C, Schittenhelm J, Skardelly M, Ernemann U, Bisdas S. Prognostic value of blood flow measurements using arterial spin labeling in gliomas. PloS One. 2014;9(6):e99616.

    Article  PubMed Central  PubMed  Google Scholar 

  19. Jansen NL, Suchorska B, Wenter V, Eigenbrod S, Schmid-Tannwald C, Zwergal A, Niyazi M, Drexler M, Bartenstein P, Schnell O, Tonn JC, Thon N, Kreth FW, la Fougère C. Dynamic 18F-FET PET in newly diagnosed astrocytic low-grade glioma identifies high-risk patients. J Nucl Med. 2014;55(2):198–203.

    Article  CAS  PubMed  Google Scholar 

  20. Bisdas S, Nägele T, Schlemmer HP, Boss A, Claussen CD, Pichler B, Ernemann U. Switching on the lights for real-time multimodality tumor neuroimaging: the integrated positron-emission tomography/MR imaging system. AJNR Am J Neuroradiol. 2010;31(4):610–4.

    Article  CAS  PubMed  Google Scholar 

  21. Nasrallah IM, Wolk DA. Multimodality imaging of Alzheimer disease and other neurodegenerative dementias. J Nucl Med. 2014;55(12):2003–11.

    Article  CAS  PubMed  Google Scholar 

  22. Stoessl AJ, Martin WW, McKeown MJ, Sossi V. Advances in imaging in Parkinson’s disease. Lancet Neurol. 2011;10(11):987–1001.

    Article  PubMed  Google Scholar 

  23. Tang CC, Poston KL, Eckert T, Feigin A, Frucht S, Gudesblatt M, Dhawan V, Lesser M, Vonsattel JP, Fahn S, Eidelberg D. Differential diagnosis of parkinsonism: a metabolic imaging study using pattern analysis. Lancet Neurol. 2010;9(2):149–58.

    Article  PubMed  Google Scholar 

  24. Barthel H, Schroeter ML, Hoffmann KT, Sabri O. PET/MR in dementia and other neurodegenerative diseases.Semin Nucl Med. 2015;45(3):224–33.

    Article  PubMed  Google Scholar 

  25. Cochrane CJ, Ebmeier KP. Diffusion tensor imaging in parkinsonian syndromes: a systematic review and meta-analysis. Neurology. 2013;80(9):857–64.

    Article  PubMed Central  PubMed  Google Scholar 

  26. Felicio AC, Shih MC, Godeiro-Junior C, Andrade LA, Bressan RA, Ferraz HB. Molecular imaging studies in Parkinson disease: reducing diagnostic uncertainty. Neurologist. 2009;15(1):6–16.

    Article  PubMed  Google Scholar 

  27. Griffa A, Baumann PS, Thiran JP, Hagmann P. Structural connectomics in brain diseases. NeuroImage. 2013;80:515–26.

    Article  PubMed  Google Scholar 

  28. Jadvar H, Colletti PM. Competitive advantage of PET/MRI. Eur J Radiol. 2014;83(1):84–94.

    Article  PubMed Central  PubMed  Google Scholar 

  29. Ding YS, Chen BB, Glielmi C, Friedman K, Devinsky O. A pilot study in epilepsy patients using simultaneous PET/MR. Am J Nucl Med Mol Imaging. 2014;4(5):459–70.

    PubMed Central  PubMed  Google Scholar 

  30. Storti SF, Boscolo Galazzo I, Del Felice A, Pizzini FB, Arcaro C, Formaggio E, Mai R, Manganotti P. Combining ESI, ASL and PET for quantitative assessment of drug-resistant focal epilepsy. Neuroimage. 2014;102(Pt 1):49–59.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Diagnostic and Interventional Neuroradiology, Eberhard Karls University Hospital, Hoppe-Seyler Str. 3, 72076, Tübingen, Germany

    S. Bisdas MD, MSc (Advanced Oncology) & U. Ernemann MD

  2. Department of Nuclear Medicine and Molecular Imaging, Eberhard Karls University Hospital, Tübingen, Germany

    C. lá Fougere MD

Authors
  1. S. Bisdas MD, MSc (Advanced Oncology)
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. lá Fougere MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. U. Ernemann MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S. Bisdas MD, MSc (Advanced Oncology).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bisdas, S., lá Fougere, C. & Ernemann, U. Hybrid MR-PET in Neuroimaging. Clin Neuroradiol 25 (Suppl 2), 275–281 (2015). https://doi.org/10.1007/s00062-015-0427-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00062-015-0427-6

Keywords

Search

Navigation